4-Ipomeanol (4-IM) toxicity through induction of cytochrome CYP4B1 under an EGR1 promoter

被引：0
|
作者：
Hsu, H
Rainov, NG
Sun, F
Sakamoto, KM
Spear, MA
机构：
[1] Univ Calif San Diego, Ctr Canc, Translat Canc Res Program, Gene Therapy Program, San Diego, CA 92103 USA
[2] Univ Halle Wittenberg, Dept Neurosurg, Mol Neurooncol Lab, Halle, Germany
[3] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Dept Pediat, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Dept Pathol, Los Angeles, CA USA
来源：
CANCER GENE THERAPY | 1999年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
PD87
引用
下载
收藏
页码：S23 / S23
页数：1
相关论文
共 50 条
  • [1] Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter
    Hsu, H
    Rainov, NG
    Quinones, A
    Eling, DJ
    Sakamoto, KM
    Spear, MA
    ANTICANCER RESEARCH, 2003, 23 (3B) : 2723 - 2728
  • [2] CYP4B1 ACTIVATES 4-IPOMEANOL IN RAT LUNG
    VERSCHOYLE, RD
    PHILPOT, RM
    WOLF, CR
    DINSDALE, D
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 123 (02) : 193 - 198
  • [3] Bioactivation of 4-Ipomeanol by CYP4B1: Adduct characterization and evidence for an enedial intermediate
    Baer, BR
    Rettie, AE
    Henne, KR
    CHEMICAL RESEARCH IN TOXICOLOGY, 2005, 18 (05) : 855 - 864
  • [4] Generation and Characterization of a Cyp4b1 Null Mouse and the Role of CYP4B1 in the Activation and Toxicity of Ipomeanol
    Parkinson, Oliver T.
    Liggitt, H. Denny
    Rettie, Allan E.
    Kelly, Edward J.
    TOXICOLOGICAL SCIENCES, 2013, 134 (02) : 243 - 250
  • [5] Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol
    Wiek, Constanze
    Schmidt, Eva M.
    Roellecke, Katharina
    Freund, Marcel
    Nakano, Mariko
    Kelly, Edward J.
    Kaisers, Wolfgang
    Yarov-Yarovoy, Vladimir
    Kramm, Christof M.
    Rettie, Allan E.
    Hanenberg, Helmut
    BIOCHEMICAL JOURNAL, 2015, 465 : 103 - 114
  • [6] Reactive intermediates of 4-ipomeanol formed by CYP4B1: Evidence for an ene-dial intermediate
    Baer, BR
    Henne, KR
    Rettie, AE
    DRUG METABOLISM REVIEWS, 2004, 36 : 224 - 224
  • [7] Synthesis and Evaluation of a 18F-Labeled 4-Ipomeanol as an Imaging Agent for CYP4B1 Gene Prodrug Activation Therapy
    Moon, Byung Seok
    Jang, Su Jin
    Kim, Sung Joo
    Lee, Tae Sup
    Chi, Dae Yoon
    Lee, Byung Chul
    Kang, Joo Hyun
    Kim, Sang Eun
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (08) : 588 - 597
  • [8] Re-engineering of human CYP4B1 for optimal catalytic processing of 4-ipomeanol and use as a suicide gene in adoptive cell therapy
    Wiek, C.
    Roellecke, K.
    Schmidt, E. M.
    Kramm, C. M.
    Rettie, A. E.
    Hanenberg, H.
    HUMAN GENE THERAPY, 2014, 25 (11) : A50 - A50
  • [9] Structure-Activity Relationships for CYP4B1 Bioactivation of 4-Ipomeanol Congeners: Direct Correlation between Cytotoxicity and Trapped Reactive Intermediates
    Kowalski, John P.
    McDonald, Matthew G.
    Whittington, Dale
    Guttman, Miklos
    Scian, Michele
    Girhard, Marco
    Hanenberg, Helmut
    Wiek, Constanze
    Rettie, Allan E.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2019, 32 (12) : 2488 - 2498
  • [10] Spotlight on CYP4B1
    Roeder, Annika
    Huesken, Saskia
    Hutter, Michael C.
    Rettie, Allan E.
    Hanenberg, Helmut
    Wiek, Constanze
    Girhard, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
12345